Plasmodium falciparum: production and characterization of rat monoclonal antibodies specific for the sexual-stage Pfs48/45 antigen.

Suppr

超能文献

作者信息

Roeffen W, Teelen K, van As J, vd Vegte-Bolmer M, Eling W, Sauerwein R

机构信息

Department of Medical Microbiology, University Medical Centre, St. Radboud, Nijmegen, 6500 HB, The Netherlands.

出版信息

Exp Parasitol. 2001 Jan;97(1):45-9. doi: 10.1006/expr.2000.4586.

DOI:10.1006/expr.2000.4586

PMID:11207113

Abstract

摘要

相似文献

Plasmodium falciparum: production and characterization of rat monoclonal antibodies specific for the sexual-stage Pfs48/45 antigen.

Exp Parasitol. 2001 Jan;97(1):45-9. doi: 10.1006/expr.2000.4586.

[Preparation and characterization of monoclonal antibodies against erythrocyte-binding antigen 175 of Plasmodium falciparum].[恶性疟原虫红细胞结合抗原175单克隆抗体的制备与鉴定]

Di Yi Jun Yi Da Xue Xue Bao. 2005 Sep;25(9):1169-71.

Plasmodium falciparum: heterologous synthesis of the transmission-blocking vaccine candidate Pfs48/45 in recombinant vaccinia virus-infected cells.恶性疟原虫：在重组痘苗病毒感染的细胞中对传播阻断疫苗候选物Pfs48/45进行异源合成。

Exp Parasitol. 1998 Oct;90(2):165-74. doi: 10.1006/expr.1998.4315.

Plasmodium falciparum: gp195 tripeptide repeat-specific monoclonal antibody inhibits parasite growth in vitro.恶性疟原虫：gp195三肽重复序列特异性单克隆抗体在体外抑制寄生虫生长。

Exp Parasitol. 1996 Oct;84(1):74-83. doi: 10.1006/expr.1996.0091.

[Obtaining monoclonal antibodies against outer membrane glycoproteins of Entamoeba histolytica].[获取针对溶组织内阿米巴外膜糖蛋白的单克隆抗体]

Arch Invest Med (Mex). 1990;21 Suppl 1:15-22.

Plasmodium yoelii: identification of rhoptry proteins using monoclonal antibodies.约氏疟原虫：利用单克隆抗体鉴定棒状体蛋白

Exp Parasitol. 1998 Nov;90(3):230-5. doi: 10.1006/expr.1998.4340.

Plasmodium falciparum: production of human antibodies specific for the MSP-3 protein in the Hu-SPL-SCID mouse.恶性疟原虫：在人脾脏片段-严重联合免疫缺陷（Hu-SPL-SCID）小鼠中产生针对疟原虫裂殖子表面蛋白3（MSP-3）的人源抗体

Exp Parasitol. 2004 Sep-Oct;108(1-2):47-52. doi: 10.1016/j.exppara.2004.07.004.

[Cloning and sequencing of the gene coding the sexual stage antigen Pfs48/45 of Plasmodium falciparum].[恶性疟原虫有性阶段抗原Pfs48/45编码基因的克隆与测序]

Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 1998;16(6):406-10.

Immunogenicity of a recombinant malaria vaccine candidate, domain I+II of AMA-1 ectodomain, from Indian P. falciparum alleles.一种重组疟疾候选疫苗（恶性疟原虫AMA-1胞外结构域的I+II结构域，来自印度恶性疟原虫等位基因）的免疫原性。

Vaccine. 2008 Aug 18;26(35):4526-35. doi: 10.1016/j.vaccine.2008.06.031. Epub 2008 Jun 30.

A Plasmodium falciparum GLURP-MSP3 chimeric protein; expression in Lactococcus lactis, immunogenicity and induction of biologically active antibodies.一种恶性疟原虫谷氨酸富蛋白-裂殖子表面蛋白3嵌合蛋白；在乳酸乳球菌中的表达、免疫原性及生物活性抗体的诱导

Vaccine. 2004 Mar 12;22(9-10):1188-98. doi: 10.1016/j.vaccine.2003.09.017.

引用本文的文献

Structural elucidation of full-length Pfs48/45 in complex with potent monoclonal antibodies isolated from a naturally exposed individual.与从自然暴露个体中分离出的强效单克隆抗体复合的全长Pfs48/45的结构解析

Nat Struct Mol Biol. 2025 May 22. doi: 10.1038/s41594-025-01532-6.

Nanobody-mediated targeting of Plasmodium falciparum PfPIMMS43 can block malaria transmission in mosquitoes.纳米抗体介导的恶性疟原虫PfPIMMS43靶向作用可阻断疟疾在蚊子体内的传播。

Commun Biol. 2025 Apr 30;8(1):683. doi: 10.1038/s42003-025-08033-8.

Targeting Bottlenecks in Malaria Transmission: Antibody-Epitope Descriptions Guide the Design of Next-Generation Biomedical Interventions.针对疟疾传播的瓶颈：抗体-表位描述指导下一代生物医学干预措施的设计。

Immunol Rev. 2025 Mar;330(1):e70001. doi: 10.1111/imr.70001.

Target-agnostic identification of human antibodies to sexual forms reveals cross-stage recognition of glutamate-rich repeats.对性形态的人源抗体进行与靶点无关的鉴定，揭示了对富含谷氨酸重复序列的跨阶段识别。

Elife. 2025 Jan 16;13:RP97865. doi: 10.7554/eLife.97865.

Modeling the Impact of a Highly Potent Plasmodium falciparum Transmission-Blocking Monoclonal Antibody in Areas of Seasonal Malaria Transmission.模拟高效抗疟原虫传播阻断单克隆抗体在季节性疟疾传播地区的影响。

J Infect Dis. 2023 Jul 14;228(2):212-223. doi: 10.1093/infdis/jiad101.

B-Cell Epitope Mapping of the Malaria Vaccine Candidate GMZ2.6c in a Naturally Exposed Population of the Brazilian Amazon.巴西亚马逊地区自然暴露人群中疟疾候选疫苗GMZ2.6c的B细胞表位定位

Vaccines (Basel). 2023 Feb 15;11(2):446. doi: 10.3390/vaccines11020446.

A Review of Major Patents on Potential Malaria Vaccine Targets.潜在疟疾疫苗靶点的主要专利综述

Pathogens. 2023 Feb 3;12(2):247. doi: 10.3390/pathogens12020247.

Design of a stabilized non-glycosylated Pfs48/45 antigen enables a potent malaria transmission-blocking nanoparticle vaccine.稳定的非糖基化Pfs48/45抗原的设计实现了一种有效的疟疾传播阻断纳米颗粒疫苗。

NPJ Vaccines. 2023 Feb 18;8(1):20. doi: 10.1038/s41541-023-00619-9.

A human antibody epitope map of Pfs230D1 derived from analysis of individuals vaccinated with a malaria transmission-blocking vaccine.基于疟疾传播阻断疫苗接种个体的分析，鉴定 PfS230D1 蛋白的人抗体表位图谱。

Immunity. 2023 Feb 14;56(2):433-443.e5. doi: 10.1016/j.immuni.2023.01.012.

Highly potent, naturally acquired human monoclonal antibodies against Pfs48/45 block Plasmodium falciparum transmission to mosquitoes.高活性、天然产生的人源单克隆抗体可阻止恶性疟原虫 Pfs48/45 向蚊子传播。

Immunity. 2023 Feb 14;56(2):406-419.e7. doi: 10.1016/j.immuni.2023.01.009.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验